Cholesterol lowering in the older population: Time for reassessment?

QJM: An International Journal of Medicine

Volumn 94, Issue 9, 2001, Pages 457-463

  Kagansky, N ^a   Levy, S ^a   Berner, Y ^a   Rimon, E ^a   Knobler, H ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MALE; POPULATION RESEARCH; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; STROKE;

EID: 0034831374     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/94.9.457     Document Type: Review

References (32)

1. Heart disease, cancer and stroke mortality trends and their interrelations: An international perspective
2. Total serum cholesterol levels and mortality risk as a function of age: A report based on Framingham data
3. Cholesterol, diastolic blood pressure and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts
4. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial
6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
7. Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: Results from eight nations of the Seven Countries Study, 25-year follow-up
8. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years
9. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
10. Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly
11. Serum cholesterol is a risk factor for myocardial infarction in elderly men and women: The Rotterdam Study
12. High blood cholesterol in elderly men and the excess risk for coronary heart disease
13. HDL cholesterol predicts coronary heart disease mortality in older persons
14. Total but not high-density lipoprotein cholesterol is associated with coronary heart disease mortality in elderly men in Finland, Italy and the Netherlands
15. Cholesterol and heart disease in older persons and women: Review of an NHLBI workshop
16. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
17. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/Tex CAPS
18. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program
19. Stroke: The global burden
20. Cerebrovascular disease
21. Low total serum cholesterol and intracerebral hemorrhagic stroke: Is the association confined to elderly men?
22. The paradox of high risk of stroke in populations with low risk of coronary heart disease
23. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischemic strokes
24. Serum cholesterol and risk of ischemic stroke: Results of a case-control study
25. Lipids and stroke: A paradox resolved
26. Changes in plasma cholesterol levels after hospitalization for acute coronary events
27. Elevated serum cholesterol is a risk factor for both CHD and thromboembolic stroke in Hawaiian Japanese men: Implications of shared risk
28. Influence of total cholesterol, high-density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study
29. Cholesterol reduction and the risk for stroke in men: A meta-analysis of randomized, controlled trials
30. Reductase inhibitor monotherapy and stroke prevention
31. Antiatherothrombotic properties of statins: Implications for cardiovascular event reductions